Apellis Pharmaceuticals Up Nearly 16%, On Pace for Largest Percent Increase Since August 2023 -- Data Talk

Dow Jones02:25

Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday

Benzinga01:13

Astellas Receives Complete Response Letter From FDA for Izervay SNDA

Seeking AlphaNov 19 22:09

Jefferies Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating, Cuts Target Price to $57

Futu NewsNov 19 21:32 · Ratings

Apellis Pharmaceuticals (APLS) Receives a Buy From Jefferies

TipRanksNov 19 20:56 · Ratings

Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Maintains Target Price $32

Futu NewsNov 19 20:33 · Ratings